LFTD Partners Inc. LIFD Q3 2022 revenue was $11.2 million, a 27% increase compared to $8.8 million in Q3 2021.
Q3 2022 Financial Highlights
-
Net income of $423,486
-
Basic earnings per share ("EPS") of $0.03 per share
-
Diluted EPS of $0.03
-
Basic and diluted weighted average shares outstanding for the three months ended September 30, 2022 were 14.1 million and 15.9 million respectively
-
Ninth consecutive quarter of positive earnings per share during the Q3 2022.
Balance Sheet Highlights - as of September 30, 2022
-
Cash on hand of $4.4 million
-
Inventory of $6.3 million
-
Current assets of $14,6 million
-
Current ratio of 2.22
-
Working capital of $8 million
-
No secured debt
Gerard M. Jacobs, CEO of LFTD Partners, stated, "In addition to our hemp-derived cannabinoid and psychedelic products business, we are intensively working on an acquisition agreement with the owners of a growing US company outside of our industry that is pursuing expansion into Asia and the Middle East. If consummated, this exciting potential acquisition would significantly diversify our company's revenues, and very likely would cause us to pursue the listing of LFTD Partners' common stock on multiple stock exchanges."
Price Action
LFTD Partners shares were trading 4.26% lower at $2.7 per share at the time of writing Monday morning.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Giorgio Trovato on Unsplash
Related News
Despite Strong Income And Revenue Growth LFTD Stock Plunges Following Earnings Release
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.